Cells (Jul 2020)

Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms

  • Elisa Nuti,
  • Armando Rossello,
  • Doretta Cuffaro,
  • Caterina Camodeca,
  • Jens Van Bael,
  • Dries van der Maat,
  • Erik Martens,
  • Pierre Fiten,
  • Rafaela Vaz Sousa Pereira,
  • Estefania Ugarte-Berzal,
  • Mieke Gouwy,
  • Ghislain Opdenakker,
  • Jennifer Vandooren

DOI
https://doi.org/10.3390/cells9071634
Journal volume & issue
Vol. 9, no. 7
p. 1634

Abstract

Read online

A fundamental part of the immune response to infection or injury is leukocyte migration. Matrix metalloproteinases (MMPs) are a class of secreted or cell-bound endopeptidases, implicated in every step of the process of inflammatory cell migration. Hence, specific inhibition of MMPs is an interesting approach to control inflammation. We evaluated the potential of a bivalent carboxylate inhibitor to selectively inhibit the trimeric proteoform of MMP-9 and compared this with a corresponding monovalent inhibitor. The bivalent inhibitor efficiently inhibited trimeric MMP-9 (IC50 = 0.1 nM), with at least 500-fold selectivity for MMP-9 trimers over monomers. Surprisingly, in a mouse model for chemotaxis, the bivalent inhibitor amplified leukocyte influxes towards lipopolysaccharide-induced inflammation. We verified by microscopic and flow cytometry analysis increased amounts of neutrophils. In a mouse model for endotoxin shock, mice treated with the bivalent inhibitor had significantly increased levels of MMP-9 in plasma and lungs, indicative for increased inflammation. In conclusion, we propose a new role for MMP-9 trimers in tempering excessive neutrophil migration. In addition, we have identified a small molecule inhibitor with a high selectivity for the trimeric proteoform of MMP-9, which will allow further research on the functions of MMP-9 proteoforms.

Keywords